An Innovative Approach to Patient Education
|
If you are the presenter of this abstract (or if you cite this abstract in a talk or on a poster), please show the QR code in your slide or poster (QR code contains this URL). |
Abstract
CECity, in collaboration with healthcare partners, has developed an innovative approach for consumer education. This education can be used for patients, healthcare providers, pharmacies, pharmaceutical manufacturers, health plans, and government agencies. This presentation will focus on the delivery of patient education using CECity’s platform and how our web-based solution provides patients with expert, guided education and information on both their medical conditions and their medications. The my Patient Medication Education (myPME™) website is an interactive online tool centered on patient safety and medication adherence and compliance, based upon the guidelines for useful Consumer Medication Information established by the US Food and Drug Administration.
As more and more consumers desire to have greater empowerment related to the decisions affecting their health, they require greater access to the appropriate knowledge and tools. Additionally, consumers are looking for networks of people who understand their condition from first-hand experience. As a result, myPMEâ„¢ has the ability to grow to support social media and Web 2.0 in the future.
myPME™ enables patients to learn about their condition and medication at their own pace. Patients not only learn, but their level of understanding is continuously evaluated with ongoing assessments and surveys with real-time feedback to create teachable moments. The tool measures patients’ pre- and post-comprehension levels of the information presented and identifies gaps in their knowledge. Additional resources are provided as part of the program to help patients close the gaps in their understanding of their condition or their medication.
CECity works closely with content partners to design the program and ensure that what myPMEâ„¢ delivers fulfills federal Patient Package Insert (PPI), medication guide and, if applicable, other Risk Evaluation Mitigation Strategy (REMS) requirements. myPMEâ„¢ is designed to be more than just a fully FDA-compliant digital patient package insert. It also addresses the longstanding challenge of providing balanced, high-quality health information to patients in an easy-to-use format that is both understandable, trackable, and shows patients “what they don’t know that they don’t knowâ€, and then closes those gaps.
The tool has been in extensive testing with patients and healthcare providers for over six months. The official launch is scheduled for summer 2011. After launch, select healthcare providers will be using the tool with their patient populations to determine the impact of education on the adherence rates using available prescription drug data.
CECity, the industry leader in lifelong learning and performance improvement, lead the collaboration to develop myPMEâ„¢ with expert consultation from leaders in consumer medication education. CECity has applied over 15 years of research, experience, and research in the principles of adult learning and healthcare education to develop myPMEâ„¢. myPMEâ„¢ delivers the highest quality information for patients on their medical conditions and their prescribed medications. The result is a one-of-a-kind patient education and medication, safety, compliance, and adherence solution.
As more and more consumers desire to have greater empowerment related to the decisions affecting their health, they require greater access to the appropriate knowledge and tools. Additionally, consumers are looking for networks of people who understand their condition from first-hand experience. As a result, myPMEâ„¢ has the ability to grow to support social media and Web 2.0 in the future.
myPME™ enables patients to learn about their condition and medication at their own pace. Patients not only learn, but their level of understanding is continuously evaluated with ongoing assessments and surveys with real-time feedback to create teachable moments. The tool measures patients’ pre- and post-comprehension levels of the information presented and identifies gaps in their knowledge. Additional resources are provided as part of the program to help patients close the gaps in their understanding of their condition or their medication.
CECity works closely with content partners to design the program and ensure that what myPMEâ„¢ delivers fulfills federal Patient Package Insert (PPI), medication guide and, if applicable, other Risk Evaluation Mitigation Strategy (REMS) requirements. myPMEâ„¢ is designed to be more than just a fully FDA-compliant digital patient package insert. It also addresses the longstanding challenge of providing balanced, high-quality health information to patients in an easy-to-use format that is both understandable, trackable, and shows patients “what they don’t know that they don’t knowâ€, and then closes those gaps.
The tool has been in extensive testing with patients and healthcare providers for over six months. The official launch is scheduled for summer 2011. After launch, select healthcare providers will be using the tool with their patient populations to determine the impact of education on the adherence rates using available prescription drug data.
CECity, the industry leader in lifelong learning and performance improvement, lead the collaboration to develop myPMEâ„¢ with expert consultation from leaders in consumer medication education. CECity has applied over 15 years of research, experience, and research in the principles of adult learning and healthcare education to develop myPMEâ„¢. myPMEâ„¢ delivers the highest quality information for patients on their medical conditions and their prescribed medications. The result is a one-of-a-kind patient education and medication, safety, compliance, and adherence solution.
Medicine 2.0® is happy to support and promote other conferences and workshops in this area. Contact us to produce, disseminate and promote your conference or workshop under this label and in this event series. In addition, we are always looking for hosts of future World Congresses. Medicine 2.0® is a registered trademark of JMIR Publications Inc., the leading academic ehealth publisher.

This work is licensed under a Creative Commons Attribution 3.0 License.